May news includes ground-breaking FDA approvals, predictions of Alzheimer disease, and a possible biomarker for mild traumatic brain injury.
We present a selection of interesting neurology articles for the month of May in the following slides. See the slide legends for links to the article summaries.
First Alzheimer’s Patient Treated with Focused Ultrasound to Open Blood-Brain Barrier. Abstract link. **** BDNF Val66Met Predicts Cognitive Decline in the Wisconsin Registry for Alzheimer’s Prevention. Abstract link.
FDA Approves Drug to Treat ALS. FDA release. **** FDA Approves First Treatment for a Form of Batten Disease. FDA release.
Hypothalamus as a Mediator of Chronic Migraine. Abstract link. **** FDA Releases gammaCore®, the First Non-Invasive Vagus Nerve Stimulation Therapy Applied at the Neck for Acute Treatment of Pain Associated with Episodic Cluster Headache in Adult Patients. Press release.
Role of Habenula and Amygdala Dysfunction in Parkinson Disease Patients with Punding. Abstract link. **** Decrease in AÎ²42 Predicts Dopa-Resistant Gait Progression in Early Parkinson Disease. Abstract link.